Foghorn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	89.33	55.45	80.34	52.21	101.14	92.8
Short-Term Investments	90.94	188.29	153.72	293.58	53.15	92.98
Cash & Short-Term Investments	180.28	243.75	234.06	345.8	154.29	185.77
Cash Growth	-32.58%	4.14%	-32.31%	124.12%	-16.95%	1140.04%
Other Current Assets	3.84	5.85	6.12	5.6	5.27	4.92
Total Current Assets	184.12	249.6	240.18	351.4	459.56	190.69
Net Property, Plant & Equipment	18.84	32.61	42.91	49.4	56.08	62.33
Other Long-Term Assets	2.01	1.78	2.82	4.09	4.13	2.58
Total Assets	204.96	283.98	285.92	404.88	519.77	255.59
Accounts Payable	3.21	3.79	6.26	5.41	3.82	3.68
Accrued Expenses	9.82	8.53	9.11	11	9.56	9.16
Current Portion of Leases	6.76	9.07	8.52	5.97	6.99	3.98
Unearned Revenue	65.3	45.61	34.55	32.82	28.32	2.02
Total Current Liabilities	85.09	66.99	58.44	55.21	48.69	18.85
Long-Term Debt	-	-	-	-	-	19.65
Long-Term Leases	15.77	28.06	36.56	45.54	51.34	58.36
Other Long-Term Liabilities	193.76	234.46	268.12	304.03	322.87	12.55
Total Long-Term Liabilities	209.53	262.52	304.67	349.57	374.21	90.56
Total Liabilities	294.62	329.51	363.11	404.77	422.9	109.41
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-in Capital	521.12	512.52	395.2	377.23	361.13	309.13
Accumulated Other Comprehensive Income	0.02	0.14	-0.83	-3.99	-0.01	-0.01
Retained Earnings	-610.8	-558.18	-471.56	-373.14	-264.26	-162.94
Total Common Shareholders' Equity	-89.66	-45.53	-77.19	0.11	96.87	146.19
Shareholders' Equity	-89.66	-45.53	-77.19	0.11	96.87	146.19
Total Liabilities & Equity	204.96	283.98	285.92	404.88	519.77	255.59
Total Debt	22.53	37.13	45.07	51.51	58.33	82
Net Cash (Debt)	157.75	206.62	188.98	294.29	95.96	103.77
Net Cash Growth	-23.65%	9.33%	-35.78%	206.69%	-7.53%	-
Net Cash Per Share	2.51	3.76	4.50	7.08	2.58	9.39
Book Value	-89.66	-45.53	-77.19	0.11	96.87	146.19
Book Value Per Share	-1.42	-0.83	-1.84	0.00	2.61	13.23
Tangible Book Value	-89.66	-45.53	-77.19	0.11	96.87	146.19
Tangible Book Value Per Share	-1.42	-0.83	-1.84	0.00	2.61	13.23

Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q